- $58.75m
- $37.87m
- $48.47m
Gossamer Bio Inc reports results for the quarter ended in September - Earnings Summary
U.S. RESEARCH ROUNDUP- Avalonbay Communities, Dominion Energy, PayPal Holdings
Gossamer Bio Inc reports results for the quarter ended in June - Earnings Summary
Brief: Gossamer Bio Announces Second Quarter 2022 Financial Results And Provides Business Update
U.S. RESEARCH ROUNDUP- Boeing, Magnite, Unity Software
Brief: Gossamer Bio Announces $120 Mln Private Placement Financing
Gossamer Bio Inc reports results for the quarter ended in March - Earnings Summary
Brief: Gossamer Bio Announces Q1 2022 Results
Gossamer Bio Inc expected to post a loss of 77 cents a share - Earnings Preview
Nasdaq Biotech Index falls, Protagonist Therapeutics top loser
U.S. RESEARCH ROUNDUP-Darling Ingredients, Live Nation Entertainment, Natera
U.S. STOCKS ON THE MOVE-Broadcom Inc, Intuit Inc, GoDaddy Inc
U.S. STOCKS ON THE MOVE-Kellogg Co, Tesla Inc, Cango Inc
Gossamer Bio slides after bowel disease drug fails study
NASDAQ RESUMED AT 08:00 AM
Brief: Gossamer Bio Announces GB004 Topline Results From Phase 2 Shift-UC Study In Ulcerative Colitis
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM
Gossamer Bio gains as UBS starts coverage with 'buy'
Brief: Gossamer Bio Inc Files For Mixed Shelf Size Not Disclosed